http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022009448-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
filingDate 2021-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2022009448-A
titleOfInvention Heteroaryl-substituted pyridines and how to use
abstract PROBLEM TO BE SOLVED: To provide a compound for treating cystic fibrosis, a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing the same. SOLUTION: A compound of formula (I) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing the same are used. [In the formula, X 1 and X 2 may be substituted with independently selected H, halo, and 1 or more independently selected halos may be substituted with C 1-4 alkyl, etc., and R 1 is C 1-4 . R2 , such as alkyl, represents a 5- to 6-membered monocyclic heteroaryl containing 1, 2 or 3 heteroatoms independently selected from the group consisting of O, S, and N. ] [Selection diagram] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100921397-B1
priorityDate 2016-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0668094-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013038386-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012154880-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011113894-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013038373-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014526501-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018516932-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011008931-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID471661216

Total number of triples: 36.